ethylisopropylamiloride has been researched along with ferric nitrilotriacetate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bendia, E; Benedetti, A; Casini, A; D'Ambrosio, L; Di Sario, A; Feliciangeli, G; Macarri, G; Pigini, P; Ridolfi, F; Svegliati-Baroni, G; Tonnini, C | 1 |
1 other study(ies) available for ethylisopropylamiloride and ferric nitrilotriacetate
Article | Year |
---|---|
Inhibition of the NA(+)/H(+) exchanger reduces rat hepatic stellate cell activity and liver fibrosis: an in vitro and in vivo study.
Topics: Amiloride; Animals; Anti-Arrhythmia Agents; Antineoplastic Agents; Ascorbic Acid; Carcinogens; Cell Division; Collagen; Diuretics; Ferric Compounds; Ferrous Compounds; Gene Expression; Hydrogen-Ion Concentration; In Situ Nick-End Labeling; Liver; Liver Cirrhosis; Male; Nitrilotriacetic Acid; Procollagen; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Messenger; Sodium-Hydrogen Exchangers; Thymidine Phosphorylase; Transforming Growth Factor beta | 2001 |